JP20251021 — JEEP Cagrilintide
Independently TestedJEEP | Cagrilintide, last activity 3 weeks ago
4 related batch concerns
Get notified when a lab result is posted, a group test forms, or this batch is flagged by the community.
Test Results
The label says 5 mg. Janoshik weighed 5.2 mg — 4% more than the label. Your dose depends on what is really in the vial, so the steps below use the measured amount.
Draw
19 units
on a U-100 insulin syringe, for 500 mcg
Going by the label you would draw 20 units — which from this vial is actually 520 mcg, not 500 mcg.
- The vial holds dry powder: 5.2 mg of Cagrilintide, as weighed.
- Water spreads that powder evenly through the liquid: 5.2 mg ÷ 2 ml = 2.6 mg per ml.
- An insulin syringe counts in units, 100 to the ml, so each unit carries 26 mcg.
- Your dose divided by that: 500 mcg ÷ 26 mcg = 19 units.
The water changes how many units a dose takes, never how much peptide you get. Twice the water means twice the units for the same dose. What sets the dose is how much is in the vial — which is why the measured amount matters.
Arithmetic, not medical advice. Assumes a U-100 syringe and that the powder fully dissolves. The figure is from the vial that was tested; yours is from the same lot but was not weighed itself.
Related batches
5 of 5 tested
CJC-1295 NO DAC (Mod GRF 1-29), same vendor
Four concerns were raised about this batch
GYC/GGpeps
Quality concerns were raised in discussion, and six positive reports were received
NAD+, same vendor
Vendor certificate from Janoshik reports 595.85 mg
Retatrutide, same vendor
1 community mention, no summary yet
KLOW, same vendor
A community group test for this batch is forming at Janoshik
Community Intelligence
- 4 concern reports involving JP20260001
- 1 concern report involving JP20260011
- 1 concern report involving JP20250821
- 1 concern report involving 2026031310
Reported against other JEEP Cagrilintide batches, not this one.
Also known as: JP2025-1021
Activity
No community activity tracked yet.
Vendor
JEEP